These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 15982217

  • 1. Possible mechanism of metastasis in lung adenocarcinomas with a micropapillary pattern.
    Miyoshi T, Shirakusa T, Ishikawa Y, Iwasaki A, Shiraishi T, Makimoto Y, Iwasaki H, Nabeshima K.
    Pathol Int; 2005 Jul; 55(7):419-24. PubMed ID: 15982217
    [Abstract] [Full Text] [Related]

  • 2. Expression of E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: an immunohistochemical study.
    Hidaka N, Nagao T, Asoh A, Kondo Y, Nagao K.
    Mod Pathol; 1998 Nov; 11(11):1039-45. PubMed ID: 9831199
    [Abstract] [Full Text] [Related]

  • 3. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G, Scarpa A, Puppa G, Veronesi G, Spaggiari L, Pasini F, Maisonneuve P, Iannucci A, Arrigoni G, Viale G.
    Cancer; 2005 Mar 15; 103(6):1154-64. PubMed ID: 15712207
    [Abstract] [Full Text] [Related]

  • 4. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma.
    Ramasami S, Kerr KM, Chapman AD, King G, Cockburn JS, Jeffrey RR.
    J Pathol; 2000 Dec 15; 192(4):427-32. PubMed ID: 11113858
    [Abstract] [Full Text] [Related]

  • 5. [Pulmonary adenocarcinoma with micropapillary pattern: a clinicopathologic and immunohistochemical study].
    Zhang J, Liang ZY, Luo YF, Wan JW, Cao JL, Liu TH.
    Zhonghua Bing Li Xue Za Zhi; 2009 Oct 15; 38(10):651-6. PubMed ID: 20078967
    [Abstract] [Full Text] [Related]

  • 6. Gastric micropapillary carcinoma: A distinct subtype with a significantly worse prognosis in TNM stages I and II.
    Eom DW, Kang GH, Han SH, Cheon GJ, Han KH, Oh HS, Kim JH, Jang HJ, Hong SM.
    Am J Surg Pathol; 2011 Jan 15; 35(1):84-91. PubMed ID: 21164291
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical alpha- and beta-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma.
    Nozawa N, Hashimoto S, Nakashima Y, Matsuo Y, Koga T, Sugio K, Niho Y, Harada M, Sueishi K.
    Pathol Res Pract; 2006 Jan 15; 202(9):639-50. PubMed ID: 16843618
    [Abstract] [Full Text] [Related]

  • 8. Pulmonary adenocarcinoma with micropapillary component: an immunohistochemical study. Case report.
    Kuroda N, Hamauzu T, Toi M, Yamaoka K, Miyazaki E, Hiroi M, Nakata H, Taguchi H, Enzan H.
    APMIS; 2005 Jan 15; 113(7-8):550-4. PubMed ID: 16086826
    [Abstract] [Full Text] [Related]

  • 9. Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma.
    Awaya H, Takeshima Y, Amatya VJ, Ishida H, Yamasaki M, Kohno N, Inai K.
    Pathol Int; 2005 Jan 15; 55(1):14-8. PubMed ID: 15660698
    [Abstract] [Full Text] [Related]

  • 10. Structural and biological properties of a papillary component generating a micropapillary component in lung adenocarcinoma.
    Nagano T, Ishii G, Nagai K, Ito T, Kawase A, Takahashi K, Nishimura Y, Nishiwaki Y, Ochiai A.
    Lung Cancer; 2010 Mar 15; 67(3):282-9. PubMed ID: 19481833
    [Abstract] [Full Text] [Related]

  • 11. Complex formation of IQGAP1 with E-cadherin/catenin during cohort migration of carcinoma cells. Its possible association with localized release from cell-cell adhesion.
    Shimao Y, Nabeshima K, Inoue T, Koono M.
    Virchows Arch; 2002 Aug 15; 441(2):124-32. PubMed ID: 12189501
    [Abstract] [Full Text] [Related]

  • 12. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R, Serra S, Asa SL.
    Am J Surg Pathol; 2008 Mar 15; 32(3):413-9. PubMed ID: 18300809
    [Abstract] [Full Text] [Related]

  • 13. Expression pattern of the scaffold protein IQGAP1 in lung cancer.
    Nakamura H, Fujita K, Nakagawa H, Kishi F, Takeuchi A, Aute I, Kato H.
    Oncol Rep; 2005 Mar 15; 13(3):427-31. PubMed ID: 15706411
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Biochemical analysis and subcellular distribution of E-cadherin-catenin in adenocarcinomas of the gastro-oesophageal junction.
    Wijnhoven BP, Tucker ET, Dinjens WN, Tilanus HW, Pignatelli M.
    Anticancer Res; 2004 Mar 15; 24(3a):1369-75. PubMed ID: 15274297
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H, Stephens LC, Kumar R.
    Clin Cancer Res; 2006 Mar 01; 12(5):1479-86. PubMed ID: 16533771
    [Abstract] [Full Text] [Related]

  • 19. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
    Guo C, Liu QG, Yang W, Zhang ZL, Yao YM.
    Hepatobiliary Pancreat Dis Int; 2008 Oct 01; 7(5):490-6. PubMed ID: 18842495
    [Abstract] [Full Text] [Related]

  • 20. Beta-catenin mutations in pulmonary blastomas: association with morule formation.
    Sekine S, Shibata T, Matsuno Y, Maeshima A, Ishii G, Sakamoto M, Hirohashi S.
    J Pathol; 2003 Jun 01; 200(2):214-21. PubMed ID: 12754743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.